MMJ BioPharma Labs, Inc
MMJ BioPharma Labs, Inc. is one of the first United States APPROVED DEA schedule 1 Contract Organization specializing in the field of marijuana substances, Cannabinoids, and Marijuana based extracts, and concentrated products. MMJ BioPharma Labs is working toward certification and accreditation under ISO/IEC 17025 and ISO/IEC 17020.
MMJ BioPharma Labs, Inc. will provide a comprehensive menu of services ranging from analytical research and development (R&D) and quality control (QC) testing, marijuana extraction under controlled environments, cannabinoids purification, cannabis infused-product formulation.
MMJ BioPharma Labs focus is in the provision of a broad range of sophisticated, state-of-the-art quality analytical services to DEA and FDA licensed manufactures, law enforcement and other regulatory agencies.
MMJ BioPharma Labs will provide:
- A broad, innovative portfolio of platform-based technologies
- A high-performance team of experienced Pharma personnel
- Advanced research and development capabilities
- State of the art analytical and extraction equipment
- DEA Schedule 1 License for critical analytical testing, extraction, and production
We are committed to setting the standards to ensure the safety, identity, strength, purity and quality of cannabis and cannabis products being distributed for research and development with DEA approval.
MMJ BioPharma Labs Inc. will be uniquely positioned to test, extract, develop, produce and supply cannabinoids that can enable and enhance the delivery and commercial success of your marijuana research and development of FDA approved products. We look forward to working with you.
Our target services are carefully selected to ensure our resources, expertise and energy are focused on the opportunities that can bring the most benefit to all your stakeholders. We then rely on great science and passionate execution to bring these opportunities to fruition.
